Relationship of neurovascular compression to central sympathetic discharge and essential hypertension  by Smith, Paul A et al.
R
C
D
P
J
S
L
C
i
D
s
l
t
c
a
b
a
N
h
t
t
s
s
L
I
F
2
Journal of the American College of Cardiology Vol. 43, No. 8, 2004
© 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2003.11.047elationship of Neurovascular
ompression to Central Sympathetic
ischarge and Essential Hypertension
aul A. Smith, MB, CHB,* James F. M. Meaney, FRCR,† Lee N. Graham, MB, CHB,*
ohn B. Stoker, BSC, MB, CHB,* Alan F. Mackintosh, MA, MD,* David A. S. G. Mary, MB, CHB, PHD,*
tephen G. Ball, MB, BCHIR, PHD*
eeds, United Kingdom; and Dublin, Ireland
OBJECTIVES We planned to examine the relationship between neurovascular compression (NVC) of the
rostral ventrolateral medulla (RVLM) and the magnitude of central sympathetic hyperactivity
in normal subjects and in patients with untreated and uncomplicated essential hypertension
(EHT).
BACKGROUND Previously it has not been possible to establish a definitive relationship between EHT and
NVC of the RVLM, a location containing efferent sympathetic vasoconstrictor neurons.
Furthermore, the relationship between NVC and magnitude of sympathetic nerve hyperac-
tivity has not been adequately examined, despite the knowledge that hyperactivity varies
according to EHT severity.
METHODS In 83 subjects, we used magnetic resonance imaging to detect NVC and, independently,
peroneal microneurography to quantify muscle sympathetic nerve activity (MSNA), expressed
as the mean frequency of multi-unit discharge (m-MSNA) and of single units (s-MSNA).
Subjects were classified according to arterial pressure values into groups with normal (NT) (n
 24) or high-normal (HN) (n  14) arterial pressure and mild (EHT-1) (n  26) or severe
(EHT-2/3) (n  19) EHT.
RESULTS A significantly greater sympathetic activity was found in 23 subjects with NVC, compared
with 60 subjects without NVC. The prevalence of NVC and the magnitude of sympathetic
hyperactivity were greater in the EHT-1 group (p  0.05) than in the other three groups.
There was no significant difference in confounding variables between the groups. Although
increased sympathetic activity was strongly predictive of NVC, this was not significantly
related to baroreceptor sensitivity controlling the pulse interval (cardiac baroreceptor reflex
sensitivity).
CONCLUSIONS Neurovascular compression of the RVLM may cause central sympathetic activation in normal
and hypertensive populations and therefore has significant implications regarding the
pathogenesis of EHT. (J Am Coll Cardiol 2004;43:1453–8) © 2004 by the American
College of Cardiology Foundatione
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ientral sympathetic hyperactivity has long been implicated
n the pathogenesis of essential hypertension (EHT) (1,2).
espite extensive research, the precise cause of this central
ympathetic activation remains unclear. The rostral ventro-
ateral medulla (RVLM) is an area rich in central sympa-
hetic neurons (3), and it has been proposed that neurovas-
ular compression (NVC) of the left RVLM may lead to
ctivation of these neurons and thereby EHT. There have
een numerous reports on the association between NVC
nd hypertension (4,5), and a microsurgical approach to
VC has been employed to treat patients with intractable
ypertension (6), albeit with inconclusive results. Despite
his, there has been sparse and inadequate information on
he relationship between NVC and the magnitude of central
ympathetic output (7–11), as either indirect indexes of
ympathetic activity have been used or the confounding
From the *Departments of Cardiology and Radiology, Leeds Teaching Hospitals,
eeds, United Kingdom; and the †MRI Department, St. James’s Hospital, Dublin,
reland. This work was funded by the British Heart Foundation (grant no.
S/2000068).
Manuscript received July 17, 2003; revised manuscript received November 17,b003, accepted November 25, 2003.ffects of antihypertensive treatment have not been ex-
luded. Furthermore, the complex relationship between
rterial pressure level and sympathetic activity has not been
aken into account. Previously, using the mean frequency of
ingle units of muscle sympathetic nerve activity (s-MSNA),
he magnitude of central sympathetic activity has been
hown to vary according to the level of arterial pressure in
ntreated groups of normal and hypertensive subjects (12).
The present study was therefore planned to determine the
elationship between NVC and the magnitude of central
ympathetic vasoconstrictor nerve output to the skeletal
uscle vascular bed. This was undertaken in populations
ith untreated and uncomplicated EHT and normotension,
lassified according to the Joint National Committee
JNC)-VI criteria (13).
ETHODS
ubjects. The study involved a consecutive series of 95
ntreated Caucasian subjects who were prospectively exam-
ned between 1999 and 2002. Twelve subjects were excluded
ecause of either an inability to obtain stable microneuro-
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RVLM Compression and Sympathetic Activity April 21, 2004:1453–8raphic data (n  7), a failed magnetic resonance examina-
ion due to claustrophobia (n  4), or poor magnetic
esonance image quality (n 1). Of the 83 subjects studied,
0 were women and 43 were men, ranging in age between
6 and 73 years. All subjects were screened by a history,
hysical examination, and laboratory study. Patients with
omplicated or secondary hypertension (including those
ith left ventricular hypertrophy) were excluded, as were
hose with arrhythmia or chronic disease, which may influ-
nce the autonomic nervous system. All subjects had similar
ietary habits, in particular, a sodium intake of 400
mol/day. Each subject provided informed, written consent
o be in the investigation, which was performed under the
pproval of the Leeds Health Authority Ethical Committee.
Values of arterial pressure were based on the average of at
east three recordings taken in a seated position on separate
ccasions in the clinic setting, and this was used to classify
roups according to JNC-VI criteria (13). Thus, subjects
lassified as NT had systolic and diastolic pressures of130
nd 85 mm Hg, respectively; those classified as HN had
ither systolic pressure of 130 to 139 mm Hg or diastolic
ressure of 85 to 89 mm Hg; those classified as EHT-1 had
ystolic or diastolic pressure of 140 to 159 or 90 to 99 mm
g, respectively; and those classified as EHT-2/3 had
espective values of 160 or 100 mm Hg. Blood pressure
BP) status was confirmed using ambulatory BP monitoring
TRACKER NIBP2, Reynolds Medical Ltd., Hertford,
nited Kingdom).
agnetic resonance imaging. Magnetic resonance imag-
ng was performed using a 1.5-T Philips Gyroscan
CS-NT (Philips Medical Systems, Eindhoven, the Neth-
rlands) with a standard head coil. Images were obtained
sing a three-dimensional, fast-field, gradient-echo, “time-
f-flight” sequence (repetition time [TR] 30 ms, echo time
TE] 7 ms, flip angle 15°, scan matrix 256  192, field of
iew 220  150 mm, 64  0.8-mm-thick slices centered
ver the posterior fossa were generated) (14,15).
Abbreviations and Acronyms
BRS  baroreceptor reflex sensitivity
EHT  essential hypertension
EHT-1  group classification for mild essential
hypertension
EHT-2/3  group classification for severe essential
hypertension
HN  group classification for high-normal arterial
pressure
JNC  Joint National Committee
m-MSNA  multi-unit muscle sympathetic nerve activity
NT  group classification for normal arterial
pressure
NVC  neurovascular compression
RVLM  rostral ventrolateral medulla
s-MSNA  single-unit muscle sympathetic nerve
activitySource axial images were inspected for the presence or sbsence of blood vessel contact with the left ventrolateral
edulla. The three-dimensional nature of the acquisition
llowed the reviewer to reformat the anatomy in multiple
lanes and to identify the vessel responsible for compression
y applying a maximum-intensity projection algorithm.
eurovascular compression was defined by the absence of
black” cerebrospinal fluid between the “white” of the blood
essel and the “grey” of the left-hand side of the medulla
ithin 10 mm of the ponto-medullary junction (Fig. 1). All
mages were assessed by two reviewers, independently of
ther variables, and a consensus decision was reached as to
he presence or absence of NVC.
icroneurography. The details of the microneurography
rotocol have been published previously (12,16). Briefly,
igure 1. An example of a “positive” case of NVC. (A) An axial image just
elow the pontomedullary junction (PMJ) showing a vessel in contact with
he left ventrolateral medulla (solid arrow). The two high-signal-intensity
tructures (solid and open arrows) represent a high-looping left posterior
nferior cerebellar artery (PICA). The reformatted maximum intensity
rojection (MIP) angiogram images demonstrate a high-looping left PICA
n the lateral (B) and antero-posterior (C) projections. Note the position of
he loop in relation to the PMJ. The position of the slice shown in A is
enoted by the dotted line for reference. C  cerebellum; M  medulla;
 pons.tudies were performed under similar conditions between
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April 21, 2004:1453–8 RVLM Compression and Sympathetic Activityhe hours of 9 AM and 12 PM. Also, subjects were asked to
ave only a light breakfast and to empty their bladders
efore commencing the study. In addition, they were asked
o avoid nicotine and caffeine products for 12 h, as well as
lcohol and strenuous exercise for 24 h before the investi-
ation. Changes in heart rate and arterial pressure were
ssessed using standard electrocardiography and a Finapres
evice (FINAPRES 2300, Ohmeda, Herts, United
ingdom).
Post-ganglionic MSNA was recorded from the right
eroneal nerve, as previously described (12,16). Briefly, the
eural signal was amplified (50,000) and was sampled at
2,000 samples/s. From this original signal, multi-unit
SNA (m-MSNA) bursts were obtained as the average
oltage after filtering (bandwidth of 700 to 2,000 Hz) and
ntegrating (time constant 0.1 s), and alongside, other data
ere digitized at 2,000 samples/s (8 bits). Single units
s-MSNA), based on consistent original action potential
orphology, with vasoconstrictor properties were obtained
rom the neural signal. Their vasoconstrictor function was
ssessed by appropriate responses to spontaneous changes in
rterial pressure, the Valsalva maneuver, and isometric
and-grip exercise.
Data were obtained from 5-min recordings during steady
able 1. Characteristics of the 83 Subjects Classified According
o the Presence or Absence of Neurovascular Compression
Variable NVC () NVC ()
ales/females (n) 34/26 9/14
ge (yrs) 49  1.4 50  2.5
Range 26–73 26–69
MI (kg/m2) 27  0.5 27  0.9
eight (kg) 79  1.8 80  3.2
eart rate (beats/min) 68  1.4 67  2.0
ystolic BP (mm Hg) 143  2.4 148  4.0
iastolic BP (mm Hg) 91  1.7 92  1.8
AP (mm Hg) 108  1.6 111  2.4
ata are presented as the mean value  SEM. There were no statistically significant
ifferences in any variable between the two groups.
BMI  body mass index; BP  blood pressure; MAP  mean arterial pressure;
VC () and NVC () with and without neurovascular compression, respectively.
Table 2. Characteristics of the 83 Subjects Cla
and Criteria of JNC-VI (13)
Variable
Normal
BP
(NT)
H
Males/females (n) 11/13
Age (yrs) 46  2.5
Range 26–68
BMI (kg/m2) 26  0.8
Weight (kg) 76  2.5
Heart rate (beats/min) 65  1.9
Systolic BP (mm Hg) 125  1.0
Diastolic BP (mm Hg) 80  0.8
MAP (mm Hg) 95  1.0
*p  0.05 and †p  0.001 by analysis of variance. Data are
EHT-1  group classification for mild essential hype
hypertension; HN  group classification for high-normal
pressure; Other abbreviations as in Table 1.tate at rest. The mean frequency of s-MSNA and that of
-MSNA bursts were counted from the same record. The
ormer was objectively obtained using an electronic discrim-
nator and was expressed as the mean frequency per 100
ardiac beats (17). The frequency of MSNA bursts was
btained from bursts with a signal to noise ratio of 3 and
ere quantified in a similar manner. The variability of
easuring both s-MSNA and MSNA in this laboratory was
imilar and did not exceed 10% (12). The baroreceptor
eflex sensitivity controlling the heart interval (cardiac BRS)
as obtained during the fourth phase of the Valsalva
aneuver as the slope of the best linear relationship between
ystolic BP and its pulse interval or the succeeding one
18,19).
nalysis and statistics. One-way analysis of variance with
ewman-Keuls post-test comparisons was used to compare
ata between the four groups. The same analysis was used
reviously to compare data between hypertensive groups
12,18). The Student unpaired t test was used to compare
wo independent groups of subjects with respect to sympa-
hetic nerve activity or BRS. Regression analysis was used to
xamine the relationship between systolic BP (as the inde-
endent variable) and the pulse interval (as the dependent
ariable). Stepwise logistic regression was used to examine
he relationship between the continuous data (sympathetic
ctivity) and categorical data (presence or absence of NVC).
lso, categorical data were compared using chi-square tests.
alues of p  0.05 were considered statistically significant.
ata are presented as the mean value  SEM.
ESULTS
he characteristics of the 83 subjects examined are shown in
able 1, according to the presence or absence of NVC, and
n Table 2, according to the level of arterial pressure,
lassified using JNC-VI criteria (13), as this is known to be
ccompanied by different sympathetic activity levels (12).
here were no statistically significant differences in age,
ender, body weight, and mass index between any of the
d According to the Level of Arterial Pressure
ormal
)
Mild
Hypertension
(EHT-1)
Severe
Hypertension
(EHT-2/3)
6 12/14 12/7
2.7 49  2.1 52  2.7
64 26–73 26–69
0.8 27  0.8 28  1.1
3.7 79  2.9 83  3.7
3.0 67  1.9 74  2.6*
1.0 149  1.1 170  3.2†
1.2 95  0.8 101  1.3†
0.9 113  0.9 124  1.5†
ted as the mean value  SEM.
on; EHT-2/3  group classification for severe essential
l pressure; NT  group classification for normal arterialssifie
igh-N
BP
(HN
8/
49 
33–
27 
82 
66 
136 
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102 
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RVLM Compression and Sympathetic Activity April 21, 2004:1453–8roups. As expected, the average indexes of arterial BP were
ignificantly different between the four groups, and, as
reviously reported (20), the heart rate was slightly higher in
he EHT-2/3 group (Table 2).
resence or absence of NVC. When all of the patients
ere considered regardless of arterial pressure level, NVC
as found in 23 (28%) of the 83 subjects examined (Table
). Those with NVC had significantly greater s-MSNA (by
6%) and MSNA (by 14%) than those without (Fig. 2A),
lthough both groups had a similar value of cardiac BRS
Fig. 2B). Both s-MSNA (p 0.03) and MSNA (p 0.04)
ere predictive of NVC.
Within the hypertensive groups, 15 patients with NVC
ere closely matched for age, body mass index, body weight,
nd arterial pressure level with 15 patients without NVC.
he magnitude of s-MSNA (72  3.5 vs. 57  2.1
mpulses/100 beats) and MSNA (62  3.1 vs. 51  2.1
ursts/100 beats) was 26% and 21% greater, respectively (at
igure 2. (A) Muscle sympathetic nerve activity (MSNA) (open bars) and
B) single-unit MSNA (s-MSNA) (solid bars) cardiac baroreceptor reflex
ensitivity (BRS) in subjects with neurovascular compression, NVC (),
nd without, NVC (). The numbers in parentheses below the x-axis
epresent the number of subjects. Data are expressed as the mean (height
f columns)  SEM (bars). The unpaired t test was used to test for
tatistical significance (ns  not significant).east p 0.01) in the group with NVC. Also, there were no (ignificant differences in cardiac BRS (3.8  0.6 vs. 3.2 
.5 ms/mm Hg).
Within the normotensive groups (arterial pressure
140/90 mm Hg), eight subjects with NVC had greater
-MSNA (55  6.3 vs. 40  5.0 impulses/100 beats) and
SNA (50  5.8 vs. 35  5.7 bursts/100 beats) than eight
ubjects without NVC (at least p  0.05), matched closely
or age, body mass index, body weight, and arterial pressure
evel. Again, there were no significant differences in cardiac
RS (5.4  1.1 vs. 5.0  1.3 ms/mm Hg).
agnitude of sympathetic activity and arterial pressure
evel. The prevalence of NVC in the four groups of
atients is depicted according to the level of arterial pressure
nd its associated magnitude of sympathetic discharge (Fig.
). As previously reported (12), s-MSNA was greater in the
HT-1 than in either the HN or EHT-2/3 group, greater
n the HN than in the NT group, and greater in the
HT-2/3 than in the HN group. Also, MSNA was greater
n the EHT-2/3 than in the HN and NT groups, but
imilar in magnitude in the EHT-1 and EHT-2/3 groups.
In these groups, the prevalence of NVC was greatest in
he EHT-1 group and was higher in the HN than in the
T group, although only the former attained statistical
ignificance (p  0.05). Considering patients within the
HT-1 group, there was greater s-MSNA (76  4.1 vs. 61
1.8 impulses/100 beats) and MSNA (64  3.8 vs. 57 
.4 bursts/100 beats) values in those with NVC. Further-
ore, the s-MSNA values relative to those of MSNA
igure 3. Sympathetic activity quantified per 100 cardiac beats in groups
lassified according to the level of arterial pressure. The numbers in
arentheses below the x-axis represent the proportions and ratios of
ubjects with neurovascular compression. Analysis of variance with
ewman-Keuls post-test comparisons was used to determine statistical
ignificance. Compared with normal subjects (NT): *p  0.05, °p  0.01,
p  0.001. Compared with high-normal arterial pressure subjects (HN):
p  0.05, p  0.001. Compared with mild essential hypertension
ubjects (EHT-1): ¶p  0.05. EHT-2/3  severe essential hypertension
ubjects; MSNA  muscle sympathetic nerve activity; s-MSNA 
ingle-unit muscle sympathetic nerve activity.obtained as the ratio of s-MSNA to MSNA in units of
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April 21, 2004:1453–8 RVLM Compression and Sympathetic Activitympulses/burst) were greater in those with NVC (1.2 
.07) than in those without (1.1  0.02), although this did
ot attain statistical significance. Cardiac BRS was signifi-
antly (p  0.05) depressed in the EHT-1 (2.9  0.3
s/mm Hg) and EHT-2/3 groups (2.5  0.3 ms/mm Hg)
elative to both the HN (5.4  0.5 ms/mm Hg) and NT
5.7  0.6 ms/mm Hg) groups.
ISCUSSION
sing the mean frequency of sympathetic discharge from
ingle-unit and multi-unit burst recordings, this study has
hown, for the first time, that a direct relationship exists
etween NVC of the RVLM and an increase in the level of
entral sympathetic discharge in both normal and hyperten-
ive populations. This relationship occurred particularly in
atients with mild hypertension in whom a higher preva-
ence of NVC and a greater magnitude of sympathetic nerve
ctivity were found. These findings imply that NVC may be
cause for central sympathetic hyperactivity and thereby
ypertension in some people.
To avoid confounding factors, we examined Caucasian
ubjects, as reported evidence suggests that race can affect
he responses of MSNA (21). All studies were undertaken
ithin the same environmental conditions and while avoid-
ng the confounding effect of visceral distention (22,23).
onsidering all subjects in the present study, the groups
ere similar with respect to the confounding factors of age
nd gender (24), as well as body mass index (25). When
ubjects were classified according to JNC-VI criteria (13),
he EHT-2/3 group had a higher heart rate than did the
ther three groups, as previously reported (20). As such,
easures of sympathetic activity were expressed per 100
ardiac beats to avoid interference from the differing heart
ates (17). In addition, when further analysis was under-
aken using groups of normotensive or hypertensive subjects
losely matched for age, body mass index, arterial pressure
evel, and heart rate, similar results were found with respect
o the relationship between NVC and central sympathetic
ischarge.
In a previous report examining two hypertensive groups
11), it was found that the frequency of MSNA bursts was
reater in the group with NVC. Unlike the present study,
owever, both groups were receiving antihypertensive ther-
py, and left ventricular hypertrophy was not excluded; both
actors may affect MSNA bursts (26,27). The present study
as gone further to show that NVC is closely related to
ympathetic hyperactivity in both normal and hypertensive
opulations; previous reports have shown that sympathetic
erve activity is greater in mild than in more severe EHT
nd in normotensive subjects with a higher arterial pressure
elative to those with optimal arterial pressure (12). In
greement with this, and further supporting the relationship
etween NVC and sympathetic hyperactivity, the preva-
ence of NVC was shown to vary according to the level of
rterial pressure in this study. Also, the presence of NVC in tormal subjects helps to refute the possibility that NVC
ight be due to tortuous, ectatic cerebral vessels resulting
rom chronic hypertension. Furthermore, the present study
xamined, for the first time, the mean frequency of single-
nit activity (s-MSNA) in relation to NVC. In comparison
o m-MSNA bursts, this is more likely to represent the
entral frequency of the sympathetic discharge supplying the
eriphery (12,18). In this respect, the group with mild
ypertension (EHT-1) had relatively greater s-MSNA than
SNA values and also a greater prevalence of NVC, as
ompared with the other three groups. Finally, the relation-
hip of NVC to sympathetic activation, but not to cardiac
RS levels, is also consistent with a central rather than
eripheral reflex mechanism leading to sympathetic nerve
yperactivity. These factors further support a relationship
etween NVC and increased sympathetic output from the
VLM.
The present results may also provide an explanation for
he inconsistent relationship between NVC, normotension,
nd hypertension reported in previous studies (28), as well
s for the variable effects of microsurgical decompression of
he RVLM on the level of arterial pressure in hypertensive
atients (6). The present study showed that NVC is more
ikely to be present in hypertensive subjects with excessive
entral sympathetic hyperactivity and may occur more often
n normal subjects with higher arterial pressure and sympa-
hetic activity than in those with optimal levels of arterial
ressure. These considerations suggest that a primary effect
f NVC can only be adequately examined in relation to the
agnitude of sympathetic activation, and this, in turn, is
elated to the various levels of arterial pressure values and
everity of hypertension.
A further implication of this study is that NVC leads to
ympathetic activation by a direct effect on the RVLM,
ather than by attenuating the afferent baroreceptor reflex
nput, which is known to inhibit sympathetic discharge. In
revious reports, there is evidence that pulsatile compression
f the RVLM in dogs (29) and in a primate model (30) may
ncrease vascular resistance and arterial pressure, thereby
ndicating an increased sympathetic output. In the current
tudy, it was shown that NVC was significantly related to
ympathetic activation and not to cardiac BRS. These
onsiderations support the view that vascular contact with
he RVLM may activate central sympathetic output rather
han preventing the afferent inhibitory effect of the barore-
ex mechanism (11).
Regardless of the exact mechanism of NVC-related
ympathetic activation, our observations may be relevant to
he understanding and management of EHT. The results
upport the concept of an important role for sympathetic
yperactivity in the pathogenesis of EHT (1,2). Further-
ore, EHT-related sympathetic hyperactivity has been
mplicated in the development of target-organ damage
2,27). The greater prevalence of NVC in hypertensive and
ormal subjects with sympathetic activation, as shown in
his study, would suggest that NVC may be indirectly
(
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RVLM Compression and Sympathetic Activity April 21, 2004:1453–8through sympathetic hyperactivity) related to the patho-
enesis and complications of EHT. In the present investi-
ation, the group with severe hypertension had a lower level
f sympathetic activity and NVC prevalence than did the
ild hypertension group. This may have arisen because we
xcluded patients with treated and complicated hyperten-
ion in order to avoid their confounding effects on sympa-
hetic output. It could also be argued that excessive sympa-
hetic output in relation to NVC may lead to hypertension
omplicated by target-organ damage, a condition that is less
ikely to occur in the absence of NVC and lower sympa-
hetic drive. These aspects would be clarified in current
ongitudinal studies, which examine the progress of sympa-
hetic activation in time and may have important implica-
ions in the management of EHT.
onclusions. The present findings suggest that NVC of
he RVLM may be a cause of central sympathetic activation
n normal and hypertensive populations, and therefore has
ignificant implications regarding the pathogenesis of EHT
n some people.
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